COVID-19 IMPACT ANALYSIS
Timely market intelligence is paramount in these uncertain times!
- Market Size numbers with existing Pre-COVID scenario compared with Post COVID scenario
- Forecasts predicted based on post-COVID scenario
- Trends, drivers and challenges including impacts of COVID scenario
1 HOUR FREE ANALYST TIME:
Speak directly to the research team to clarify any post purchase queries you may have.
P.S The current version of the report will be delivered immediately. The new version with the COVID-19 Impact Analysis will be delivered within 3 business days.
About drug device combination products
Drug device combination products consist of two regulated components: an active pharmaceutical ingredient and a medical device. These two standardized components are combined, either chemically or physically for developing one component. The drugs present in the device are either impregnated or surface coated. The drug device combination products are considered to be highly innovative in the area of advanced healthcare such as biomedical nanotechnology and development of regenerative medicine.
Technavio's analysts forecast the global drug
device combination products market to grow at a CAGR of 11.95% over the period 2014-2019.
Covered in this report The report includes the present scenario and the growth prospects of the global drug device combination products market for 2015-2019. The market can be segmented by product type:
- Drug eluting stent
- Prefilled syringes
- Wearable injectors
- Insulin delivery systems
Technavio's report, Global Drug Device Combination Products Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, APAC, and EMEA; it also covers the landscape of the global drug device combination products market and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.
Key regions
- Americas
- APAC
- EMEA
Key Vendors
- Abbott Laboratories
- Becton, Dickinson and Company
- Boston Scientific
- Medtronic
- Roche Diagnostics
Other prominent vendors
- Aerogen
- Airon
- Allied Healthcare Products
- AstraZeneca
- B. Braun Medical
- BIOTRONIK
- Boehringer Ingelheim
- Briggs Healthcare
- C.R. Bard
- Cardinal Health
- Clement Clarke International
- Concordia
- Consort Medical
- Cook Medical
- DeVilbiss Healthcare
- Ethicon
- Gerresheimer
- GlaxoSmithKline
- Heyer Medical
- Invacare
- Lepu Medical Technology
- Mallinckrodt
- Medline Industries
- MicroPort Scientific
- Mylan
- Nypro
- Omron Healthcare
- PARI Medical
- Phillips Healthcare
- RPC Bramlage
- Salter Labs
- Smart inhaler
- Stryker
- Sunovion Pharmaceuticals
- Teleflex
- Terumo
- Vortran Medical
- W. L. Gore & Associates
Key market driver
- Use of home healthcare devices
- For a full, detailed list, view our report
Key market challenge
- High spending by patients
- For a full, detailed list, view our report
Key market trend
- Use of bioabsorable stents
- For a full, detailed list, view our report
Key Questions Answered in this Report- What will the market size be in 2019 and what will the growth rate be?
- What are the key market trends?
- What is driving this market?
- What are the challenges to market growth?
- Who are the key vendors in this market space?
- What are the market opportunities and threats faced by the key vendors?
- What are the strengths and weaknesses of the key vendors?